Cargando…
A qualitative assessment of factors influencing acceptance of a new rotavirus vaccine among health care providers and consumers
BACKGROUND: In 2006, a new rotavirus vaccine (RotaTeq) was licensed in the US and recommended for routine immunization of all US infants. Because a previously licensed vaccine (Rotashield) was withdrawn from the US for safety concerns, identifying barriers to uptake of RotaTeq will help develop stra...
Autores principales: | Patel, Manish M, Janssen, Alan P, Tardif, Richard R, Herring, Mark, Parashar, Umesh D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2203981/ https://www.ncbi.nlm.nih.gov/pubmed/17945010 http://dx.doi.org/10.1186/1471-2431-7-32 |
Ejemplares similares
-
Rotavirus P[4]G2 in a Vaccinated Population, Brazil
por: Patel, Manish M., et al.
Publicado: (2008) -
Influence of birth rates and transmission rates on the global seasonality of rotavirus incidence
por: Pitzer, Virginia E., et al.
Publicado: (2011) -
Global Experience With Rotavirus Vaccines
por: Burke, Rachel M, et al.
Publicado: (2021) -
Removing the Age Restrictions for Rotavirus Vaccination: A Benefit-Risk Modeling Analysis
por: Patel, Manish M., et al.
Publicado: (2012) -
The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease
por: Glass, Roger I, et al.
Publicado: (2021)